The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 11, 2012
Filed:
Mar. 16, 2011
Julian Adams, Boston, MA (US);
Mark L. Behnke, Somerville, MA (US);
Alfredo C. Castro, Winchester, MA (US);
Catherine A. Evans, Somerville, MA (US);
Louis Grenier, Newton, MA (US);
Michael J. Grogan, Winchester, MA (US);
Tao Liu, Ashland, MA (US);
Daniel A. Snyder, Somerville, MA (US);
Thomas T. Tibbitts, Westford, MA (US);
Julian Adams, Boston, MA (US);
Mark L. Behnke, Somerville, MA (US);
Alfredo C. Castro, Winchester, MA (US);
Catherine A. Evans, Somerville, MA (US);
Louis Grenier, Newton, MA (US);
Michael J. Grogan, Winchester, MA (US);
Tao Liu, Ashland, MA (US);
Daniel A. Snyder, Somerville, MA (US);
Thomas T. Tibbitts, Westford, MA (US);
Infinity Pharmaceuticals, Inc., Cambridge, MA (US);
Abstract
The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.